| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bb095f1d4da3dd53dbc1c48d210f9c6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54388
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 |
| filingDate |
2015-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fa9a24af295cfe686681c632c8087af |
| publicationDate |
2016-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016005354-A1 |
| titleOfInvention |
Autoantibody profiling in aps |
| abstract |
The invention relates to means for the prognosis and/or diagnosis of antiphospholipid syndrome (APS). In particular, the invention enables differentiation between subjects suffering and/or at risk of suffering from APS and subjects that exhibit elevated levels of antiphospholipid antibodies (aPL) without clinical manifestations or with reduced risk of exhibiting clinical manifestations or a clinical phenotype of APS. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170032330-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107402309-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107402306-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102516745-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017207855-A1 |
| priorityDate |
2014-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |